Azimuth Capital Investment Management LLC Gilead Sciences, Inc. Transaction History
Azimuth Capital Investment Management LLC
- $2.46 Billion
- Q4 2024
A detailed history of Azimuth Capital Investment Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Azimuth Capital Investment Management LLC holds 111,615 shares of GILD stock, worth $12.3 Million. This represents 0.42% of its overall portfolio holdings.
Number of Shares
111,615
Previous 110,445
1.06%
Holding current value
$12.3 Million
Previous $9.26 Million
11.36%
% of portfolio
0.42%
Previous 0.37%
Shares
11 transactions
Others Institutions Holding GILD
# of Institutions
2,090Shares Held
1.02BCall Options Held
8.73MPut Options Held
9.63M-
Black Rock Inc. New York, NY121MShares$13.3 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$12.7 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$7.88 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.4MShares$6.64 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$6.37 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $138B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...